NBIX
Price
$120.69
Change
+$4.58 (+3.94%)
Updated
Feb 21 closing price
Capitalization
13.72B
66 days until earnings call
PRGO
Price
$25.34
Change
+$0.10 (+0.40%)
Updated
Feb 21 closing price
Capitalization
4.35B
4 days until earnings call
Ad is loading...

NBIX vs PRGO

Header iconNBIX vs PRGO Comparison
Open Charts NBIX vs PRGOBanner chart's image
Neurocrine Biosciences
Price$120.69
Change+$4.58 (+3.94%)
Volume$1.96M
Capitalization13.72B
Perrigo
Price$25.34
Change+$0.10 (+0.40%)
Volume$1.88M
Capitalization4.35B
NBIX vs PRGO Comparison Chart
Loading...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NBIX vs. PRGO commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBIX is a Hold and PRGO is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (NBIX: $120.69 vs. PRGO: $25.34)
Brand notoriety: NBIX and PRGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NBIX: 152% vs. PRGO: 143%
Market capitalization -- NBIX: $13.72B vs. PRGO: $4.35B
NBIX [@Pharmaceuticals: Other] is valued at $13.72B. PRGO’s [@Pharmaceuticals: Other] market capitalization is $4.35B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBIX’s FA Score shows that 0 FA rating(s) are green whilePRGO’s FA Score has 1 green FA rating(s).

  • NBIX’s FA Score: 0 green, 5 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRGO is a better buy in the long-term than NBIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBIX’s TA Score shows that 6 TA indicator(s) are bullish while PRGO’s TA Score has 6 bullish TA indicator(s).

  • NBIX’s TA Score: 6 bullish, 5 bearish.
  • PRGO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than NBIX.

Price Growth

NBIX (@Pharmaceuticals: Other) experienced а +4.93% price change this week, while PRGO (@Pharmaceuticals: Other) price change was +3.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.14%. For the same industry, the average monthly price growth was +77.04%, and the average quarterly price growth was +50.35%.

Reported Earning Dates

NBIX is expected to report earnings on Apr 30, 2025.

PRGO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than PRGO($4.35B). PRGO has higher P/E ratio than NBIX: PRGO (341.25) vs NBIX (57.20). PRGO YTD gains are higher at: -1.439 vs. NBIX (-11.582). PRGO has higher annual earnings (EBITDA): 525M vs. NBIX (358M). NBIX has more cash in the bank: 1.03B vs. PRGO (751M). NBIX has less debt than PRGO: NBIX (428M) vs PRGO (4.07B). PRGO has higher revenues than NBIX: PRGO (4.66B) vs NBIX (1.89B).
NBIXPRGONBIX / PRGO
Capitalization13.7B4.35B315%
EBITDA358M525M68%
Gain YTD-11.582-1.439805%
P/E Ratio57.20341.2517%
Revenue1.89B4.66B41%
Total Cash1.03B751M137%
Total Debt428M4.07B11%
FUNDAMENTALS RATINGS
NBIX vs PRGO: Fundamental Ratings
NBIX
PRGO
OUTLOOK RATING
1..100
5724
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
68100
SMR RATING
1..100
5290
PRICE GROWTH RATING
1..100
8159
P/E GROWTH RATING
1..100
872
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (53) in the Pharmaceuticals Other industry is in the same range as NBIX (72) in the Biotechnology industry. This means that PRGO’s stock grew similarly to NBIX’s over the last 12 months.

NBIX's Profit vs Risk Rating (68) in the Biotechnology industry is in the same range as PRGO (100) in the Pharmaceuticals Other industry. This means that NBIX’s stock grew similarly to PRGO’s over the last 12 months.

NBIX's SMR Rating (52) in the Biotechnology industry is somewhat better than the same rating for PRGO (90) in the Pharmaceuticals Other industry. This means that NBIX’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's Price Growth Rating (59) in the Pharmaceuticals Other industry is in the same range as NBIX (81) in the Biotechnology industry. This means that PRGO’s stock grew similarly to NBIX’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for NBIX (87) in the Biotechnology industry. This means that PRGO’s stock grew significantly faster than NBIX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NBIXPRGO
RSI
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
64%
Momentum
ODDS (%)
Bearish Trend 3 days ago
66%
Bullish Trend 3 days ago
58%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bullish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
59%
Bullish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
Bearish Trend 6 days ago
60%
Bearish Trend 6 days ago
67%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
72%
Aroon
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
62%
View a ticker or compare two or three
Ad is loading...
NBIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RZB25.030.06
+0.24%
Reinsurance Group of America
BIZD17.68-0.04
-0.23%
VanEck BDC Income ETF
INTL23.56-0.06
-0.25%
Main International ETF
HIBL43.60-5.07
-10.42%
Direxion Daily S&P 500® Hi Bt Bl 3X ETF
GDXU43.66-5.17
-10.59%
MicroSectors™ Gold Miners 3X Lvrgd ETN

NBIX and

Correlation & Price change

A.I.dvisor tells us that NBIX and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
+3.94%
ACET - NBIX
25%
Poorly correlated
-2.66%
AVDL - NBIX
23%
Poorly correlated
-0.71%
SNDL - NBIX
23%
Poorly correlated
+0.57%
IMCC - NBIX
23%
Poorly correlated
-0.92%
ZOM - NBIX
23%
Poorly correlated
-0.66%
More

PRGO and

Correlation & Price change

A.I.dvisor tells us that PRGO and VTRS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRGO and VTRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+0.40%
VTRS - PRGO
32%
Poorly correlated
+1.72%
SIGA - PRGO
26%
Poorly correlated
-3.51%
ITCI - PRGO
24%
Poorly correlated
+0.05%
INDV - PRGO
22%
Poorly correlated
-6.01%
NBIX - PRGO
22%
Poorly correlated
+3.94%
More